サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1550075

分子輸送媒体市場：世界の産業分析、規模、シェア、成長、動向、2024-2032年予測

Molecular Transport Medium Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日
ページ情報
英文 336 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.30円
分子輸送媒体市場：世界の産業分析、規模、シェア、成長、動向、2024-2032年予測
出版日: 2024年09月02日
発行: Persistence Market Research
ページ情報: 英文 336 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、分子輸送媒体の世界市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を含む重要な市場ダイナミクスを徹底的に評価し、市場構造に関する詳細な洞察を提供しています。

主な洞察

  • 分子輸送媒体の市場規模（2024E）：11億4,700万米ドル
  • 市場予測値（2032F）：12億7,200万米ドル
  • 世界市場成長率（CAGR 2024年から2032年まで）：1.3%

分子輸送媒体市場- レポート範囲：

分子輸送媒体は、特に感染症の診断検査用の臨床検体の保存と輸送において重要な役割を果たしています。この培地は、正確な分子分析のためにRNAやDNAサンプルの完全性を維持するよう特別に設計されており、様々な疾患の診断に役立っています。分子輸送培地市場は、病院、診断研究所、調査機関、バイオテクノロジー企業にサービスを提供し、ウイルス、細菌、汎用輸送培地を含むさまざまな輸送ソリューションを提供しています。市場成長の原動力は、診断検査需要の増加、感染症流行の高まり、分子診断技術の進歩による検体保存と輸送効率の向上です。

市場促進要因：

世界の分子輸送媒体市場は、正確な診断検査、特にCOVID-19、インフルエンザ、その他の新興病原体のようなウイルス感染症に対するニーズの高まりなど、いくつかの重要な要因によって推進されています。感染症の世界の流行と、それに伴う分子診断のための信頼性の高い輸送ソリューションに対する需要の高まりが、市場の拡大をさらに後押ししています。ウイルス不活性化輸送培地の開発や検体保存技術の強化などの技術的進歩は、診断検査の精度を向上させ、汚染のリスクを低減し、市場の成長を促進しています。さらに、ゲノミクスや個別化医療における研究開発活動への注目の高まりは、先進的な分子検査に特化した輸送媒体を提供する市場参入者に新たな機会をもたらしています。

市場抑制要因：

有望な成長見通しにもかかわらず、分子輸送媒体市場は規制遵守、サプライチェーンの混乱、コスト制約に関連する課題に直面しています。輸送媒体の製造、輸送、使用を規定する厳しい規制は、メーカーにコンプライアンス上の負担を課し、市場参入障壁や運営コストに影響を与えます。さらに、特に世界の保健衛生上の緊急事態の際には、サプライチェーンの問題が重要な輸送媒体の不足につながり、診断検査能力に影響を及ぼす可能性があります。特殊な分子輸送媒体のコストが高く、入手可能な地域が限られていることは、特にヘルスケア予算に制約のある新興経済国において、市場浸透の課題となっています。こうした規制や物流の障壁に対処するには、安全で効果的な輸送ソリューションの継続的供給を確保するために、業界利害関係者と政策立案者の協力が必要です。

市場機会：

分子輸送媒体市場は、技術革新、調査活動の拡大、ヘルスケア提供モデルの進化を原動力とする大きな成長機会を示しています。自動化された検体ハンドリングと輸送技術の統合は、検査室の効率を高め、診断ワークフローにおける人為的ミスを減らします。さらに、個別化医療やゲノミクス研究における分子輸送媒体の応用拡大が、市場の範囲を広げ、技術革新を刺激しています。戦略的パートナーシップ、研究開発への投資、費用対効果の高い輸送ソリューションの導入は、新たな機会を活用し、ダイナミックな分子輸送ランドスケープにおける市場のリーダーシップを維持するために不可欠です。

本レポートで扱う主な質問

  • 分子輸送媒体市場の世界的成長を促す主な要因は何か？
  • どの輸送媒体のタイプと用途がさまざまなヘルスケア環境での採用を促進しているか？
  • 技術進歩は分子輸送媒体市場の競合情勢をどのように変えているのか？
  • 分子輸送媒体市場に貢献している主要プレイヤーは誰で、市場の関連性を維持するためにどのような戦略を採用しているのか？
  • 世界の分子輸送媒体市場における新たな動向と将来展望は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 主な内容

  • 製品採用分析
  • メーカーが採用した主要戦略
  • 規制シナリオ
  • PESTLE分析
  • ポーターの分析
  • バリューチェーン分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID-19危機分析

  • 2024年の市場シナリオ
  • COVID-19と影響分析
    • 製品タイプ
    • 用途別
    • サンプル別
    • エンドユーザー別
    • 地域別

第7章 世界の分子輸送媒体市場- 価格分析

  • 世界平均価格分析ベンチマーク
  • 価格の想定

第8章 世界の分子輸送媒体市場の需要（価値または規模、10億米ドル）分析

  • 市場金額（10億米ドル）分析、2019～2023年
  • 市場金額（10億米ドル）予測、2024～2032年
    • 前年比成長動向分析
    • 絶対的収益機会

第9章 製品タイプ別：世界の分子輸送媒体市場分析

  • イントロダクション/主な調査結果
  • 市場規模（10億米ドル）分析、2019～2023年
  • 市場規模（10億米ドル）分析と予測、2024～2032年
    • 能動輸送媒体
    • 不活化輸送培地

第10章 用途別：世界の分子輸送媒体市場分析

  • イントロダクション/主な調査結果
  • 市場規模（10億米ドル）分析、2019～2023年
  • 市場規模（10億米ドル）分析と予測、2024～2032年
    • ウイルス
      • COVID-19
      • 中東呼吸器症候群（MERS）
      • インフルエンザ
      • COVID-19
      • ヒト免疫不全ウイルス（HIV）
      • ライノウイルス
      • アデノウイルス
      • 呼吸器合胞体ウイルス（RSV）
    • 細菌
      • ブドウ球菌性肺炎
      • インフルエンザ菌
      • 炭疽菌
      • その他
    • 非定型細菌
      • マイコプラズマ
      • Q熱
      • その他
    • 結核菌および真菌感染症

第11章 サンプル別：世界の分子輸送媒体市場分析

  • イントロダクション/主な調査結果
  • 市場規模（10億米ドル）分析、2019～2023年
  • 市場規模（10億米ドル）分析と予測、2024～2032年
    • 鼻洗浄とスワブ
    • 喀痰
    • 唾液
    • 便と便
    • 尿
    • 血
    • ティッシュ
    • その他

第12章 エンドユーザー別：世界の分子輸送媒体市場分析

  • イントロダクション/主な調査結果
  • 市場規模（10億米ドル）分析、2019～2023年
  • 市場規模（10億米ドル）分析と予測、2024～2032年
    • 診断検査室
    • 微生物学研究所
    • 病院・クリニック
    • その他

第13章 地域別：世界の分子輸送媒体市場分析

  • イントロダクション
  • 市場規模（10億米ドル）分析、2019～2023年
  • 市場規模（10億米ドル）分析と予測、2024～2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東およびアフリカ（中東・アフリカ）

第14章 北米分子輸送媒体市場分析

第15章 ラテンアメリカの分子輸送媒体市場分析

第16章 欧州の分子輸送媒体市場分析

第17章 南アジア分子輸送媒体市場分析

第18章 東アジアの分子輸送媒体市場分析

第19章 オセアニアの分子輸送媒体市場分析

第20章 中東およびアフリカの分子輸送媒体市場分析

第21章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場集中
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Thermo Fisher Scientific
    • Becton Dickinson and Company
    • Cardinal Health
    • Quidel Corporation
    • Medical Wire &Equipment（MWE）
    • COPAN Diagnostics Inc.[COPAN Group]
    • Titan Biotech Ltd.
    • Alpha Teknova, Inc.[formerly named Teknova]
    • Bio-Genex Laboratories Inc.
    • EKF Diagnostics
    • Trinity Biotech
    • Alpha-Tec Systems, Inc.
    • Charm Sciences, Inc.
    • Azer Scientific
    • bioBoaVista
    • AccuGene
    • KSL Diagnostics
    • Puritan Medical Products
    • Amazing Biotech（Shanghai）Co., Ltd.

第23章 使用される前提条件と頭字語

第24章 調査手法

目次
Product Code: PMRREP32736

Persistence Market Research has recently released a comprehensive report on the worldwide market for molecular transport medium. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Molecular Transport Medium Market Size (2024E): USD 1.147 Billion
  • Projected Market Value (2032F): USD 1.272 Billion
  • Global Market Growth Rate (CAGR 2024 to 2032): 1.3%

Molecular Transport Medium Market - Report Scope:

Molecular transport medium plays a crucial role in preserving and transporting clinical specimens for diagnostic testing, particularly for infectious diseases. This medium is specifically designed to maintain the integrity of RNA and DNA samples for accurate molecular analysis, aiding in the diagnosis of various conditions. The molecular transport medium market serves hospitals, diagnostic laboratories, research institutions, and biotechnology companies, offering a range of transport solutions, including viral, bacterial, and general-purpose transport mediums. Market growth is driven by the increasing demand for diagnostic testing, rising prevalence of infectious diseases, and advancements in molecular diagnostics technology, enhancing specimen preservation and transportation efficiency.

Market Growth Drivers:

The global molecular transport medium market is propelled by several key factors, including the growing need for accurate diagnostic testing, particularly for viral infections like COVID-19, influenza, and other emerging pathogens. The rising prevalence of infectious diseases globally and the subsequent demand for reliable transport solutions for molecular diagnostics further drive market expansion. Technological advancements, such as the development of viral inactivation transport mediums and enhanced specimen preservation technologies, offer improved accuracy in diagnostic testing and reduce the risk of contamination, fostering market growth. Moreover, the increasing focus on research and development activities in genomics and personalized medicine creates new opportunities for market players to provide specialized transport mediums for advanced molecular testing.

Market Restraints:

Despite promising growth prospects, the molecular transport medium market faces challenges related to regulatory compliance, supply chain disruptions, and cost constraints. Stringent regulations governing the manufacturing, transportation, and use of transport mediums impose compliance burdens on manufacturers, affecting market entry barriers and operational costs. Furthermore, supply chain issues, particularly during global health emergencies, can lead to shortages of critical transport mediums, impacting diagnostic testing capacities. The high cost of specialized molecular transport mediums and limited availability in certain regions pose challenges for market penetration, particularly in emerging economies with constrained healthcare budgets. Addressing these regulatory and logistical barriers requires collaboration between industry stakeholders and policymakers to ensure the continuous supply of safe and effective transport solutions.

Market Opportunities:

The molecular transport medium market presents significant growth opportunities driven by technological innovations, expanding research activities, and evolving healthcare delivery models. The integration of automated specimen handling and transport technologies enhances laboratory efficiency and reduces human error in diagnostic workflows. Furthermore, the growing application of molecular transport mediums in personalized medicine and genomics research broadens the market scope and stimulates innovation. Strategic partnerships, investment in research and development, and the introduction of cost-effective transport solutions are essential to capitalize on emerging opportunities and sustain market leadership in the dynamic molecular transport landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the molecular transport medium market globally?
  • Which transport medium types and applications are driving adoption across different healthcare settings?
  • How are technological advancements reshaping the competitive landscape of the molecular transport medium market?
  • Who are the key players contributing to the molecular transport medium market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global molecular transport medium market?

Competitive Intelligence and Business Strategy:

Leading players in the global molecular transport medium market, including Thermo Fisher Scientific, Becton, Dickinson and Company, and COPAN Diagnostics Inc., focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced transport mediums, including viral inactivation solutions and enhanced stabilization formulas, catering to diverse diagnostic needs and research requirements. Collaborations with healthcare providers, diagnostic laboratories, and regulatory agencies facilitate market access and promote technology adoption. Moreover, emphasis on clinical research, evidence-based practice, and customer education fosters market growth and enhances specimen integrity in the rapidly evolving molecular diagnostics landscape.

Key Companies Profiled:

  • Thermo Fisher Scientific
  • Becton, Dickinson and Company
  • COPAN Diagnostics Inc.
  • Puritan Medical Products
  • BioMed Diagnostics
  • Hardy Diagnostics
  • Longhorn Vaccines & Diagnostics
  • Titan Biotech Ltd.
  • Starplex Scientific
  • HiMedia Laboratories

Key Segments Covered in Molecular Transport Medium Industry Research

Molecular Transport Medium Market by Product Type:

  • Active Transport Medium
  • Inactivated Transport Medium

Molecular Transport Medium Market by Application:

  • Virus
  • Bacteria
  • Atypical Bacteria
  • Mycobacterial and Fungal Infection

Molecular Transport Medium Market by Sample:

  • Nasal Washes and Swabs
  • Sputum
  • Saliva
  • Faecal & Stool
  • Urine
  • Blood
  • Tissues

Molecular Transport Medium Market by End User:

  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals & Clinics

Molecular Transport Medium Market by Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Inclusions

  • 4.1. Product Adoption Analysis
  • 4.2. Key Strategies Adopted by Manufacturers
  • 4.3. Regulatory Scenario
  • 4.4. PESTLE Analysis
  • 4.5. Porter's Analysis
  • 4.6. Value Chain Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Outlook
    • 5.1.2. Global Healthcare Spending Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. COVID-19 Pandemic
    • 5.2.2. Product Launches
    • 5.2.3. GDP Growth
    • 5.2.4. Increasing Prevalence of Infectious Diseases
    • 5.2.5. R&D Expenditure by Key Players
    • 5.2.6. Product Adoption Rate
    • 5.2.7. Regulatory Scenario
    • 5.2.8. Strategic Acquisitions and Mergers among Key Players
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

  • 6.1. 2024 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By Sample
    • 6.2.4. By End User
    • 6.2.5. By Region

7. Global Molecular Transport Medium Market- Pricing Analysis

  • 7.1. Global Average Pricing Analysis Benchmark
  • 7.2. Pricing Assumption

8. Global Molecular Transport Medium Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2032

  • 8.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 8.2. Current and Future Market Value (US$ Bn) Projections, 2024-2032
    • 8.2.1. Y-o-Y Growth Trend Analysis
    • 8.2.2. Absolute $ Opportunity Analysis

9. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Product Type

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis by Product Type, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Product Type, 2024-2032
    • 9.3.1. Active Transport Medium
    • 9.3.2. Inactivated Transport Medium

10. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis by Application, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Application, 2024-2032
    • 10.3.1. Virus
      • 10.3.1.1. COVID-19
      • 10.3.1.2. Middle East respiratory syndrome (MERS)
      • 10.3.1.3. Influenza
      • 10.3.1.4. COVID-19
      • 10.3.1.5. Human Immunodeficiency Virus (HIV)
      • 10.3.1.6. Rhinovirus
      • 10.3.1.7. Adenovirus
      • 10.3.1.8. Respiratory Syncytial Virus (RSV)
    • 10.3.2. Bacteria
      • 10.3.2.1. Staphylococcus pneumonia
      • 10.3.2.2. Haemophilus influenzae
      • 10.3.2.3. Anthrax
      • 10.3.2.4. Others
    • 10.3.3. Atypical Bacteria
      • 10.3.3.1. Mycoplasma
      • 10.3.3.2. Q-Fever
      • 10.3.3.3. Others
    • 10.3.4. Mycobacterial and Fungal Infection

11. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By Sample

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis by Sample, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by Sample, 2024-2032
    • 11.3.1. Nasal Washes and Swabs
    • 11.3.2. Sputum
    • 11.3.3. Saliva
    • 11.3.4. Faecal & Stool
    • 11.3.5. Urine
    • 11.3.6. Blood
    • 11.3.7. Tissues
    • 11.3.8. Others

12. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis by End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast by End User, 2024-2032
    • 12.3.1. Diagnostic Laboratories
    • 12.3.2. Microbiology Laboratories
    • 12.3.3. Hospitals & Clinics
    • 12.3.4. Others

13. Global Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Analysis by Region, 2019-2023
  • 13.3. Current Market Size (US$ Bn) Analysis and Forecast by Region, 2024-2032
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. South Asia
    • 13.3.5. East Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)

14. North America Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 14.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product Type
    • 14.3.3. By Application
    • 14.3.4. By Sample
    • 14.3.5. By End User
  • 14.4. Market Trends
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Molecular Transport Medium Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Product Type
        • 14.7.1.2.2. By Application
        • 14.7.1.2.3. By Sample
        • 14.7.1.2.4. By End User
    • 14.7.2. Canada Molecular Transport Medium Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Product Type
        • 14.7.2.2.2. By Application
        • 14.7.2.2.3. By Sample
        • 14.7.2.2.4. By End User

15. Latin America Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 15.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product Type
    • 15.3.3. By Application
    • 15.3.4. By Sample
    • 15.3.5. By End User
  • 15.4. Market Trends
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Molecular Transport Medium Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Product Type
        • 15.7.1.2.2. By Application
        • 15.7.1.2.3. By Sample
        • 15.7.1.2.4. By End User
    • 15.7.2. Argentina Molecular Transport Medium Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Product Type
        • 15.7.2.2.2. By Application
        • 15.7.2.2.3. By Sample
        • 15.7.2.2.4. By End User
    • 15.7.3. Mexico Molecular Transport Medium Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Product Type
        • 15.7.3.2.2. By Application
        • 15.7.3.2.3. By Sample
        • 15.7.3.2.4. By End User

16. Europe Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 16.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Nordic Countries
      • 16.3.1.8. Russia
      • 16.3.1.9. Rest of Europe
    • 16.3.2. By Product Type
    • 16.3.3. By Application
    • 16.3.4. By Sample
    • 16.3.5. By End User
  • 16.4. Market Trends
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Molecular Transport Medium Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Product Type
        • 16.7.1.2.2. By Application
        • 16.7.1.2.3. By Sample
        • 16.7.1.2.4. By End User
    • 16.7.2. France Molecular Transport Medium Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Product Type
        • 16.7.2.2.2. By Application
        • 16.7.2.2.3. By Sample
        • 16.7.2.2.4. By End User
    • 16.7.3. Italy Molecular Transport Medium Market
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Product Type
        • 16.7.3.2.2. By Sample
        • 16.7.3.2.3. By End User
    • 16.7.4. Spain Molecular Transport Medium Market
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Product Type
        • 16.7.4.2.2. By Application
        • 16.7.4.2.3. By Sample
        • 16.7.4.2.4. By End User
    • 16.7.5. U.K. Molecular Transport Medium Market
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Product Type
        • 16.7.5.2.2. By Application
        • 16.7.5.2.3. By Sample
        • 16.7.5.2.4. By End User
    • 16.7.6. BENELUX Union Molecular Transport Medium Market
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Product Type
        • 16.7.6.2.2. By Application
        • 16.7.6.2.3. By Sample
        • 16.7.6.2.4. By End User
    • 16.7.7. Nordic Countries Molecular Transport Medium Market
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Product Type
        • 16.7.7.2.2. By Application
        • 16.7.7.2.3. By Sample
        • 16.7.7.2.4. By End User
    • 16.7.8. Russia Molecular Transport Medium Market
      • 16.7.8.1. Introduction
      • 16.7.8.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.8.2.1. By Product Type
        • 16.7.8.2.2. By Application
        • 16.7.8.2.3. By Sample
        • 16.7.8.2.4. By End User

17. South Asia Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 17.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Vietnam
      • 17.3.1.6. Philippines
      • 17.3.1.7. Rest of South Asia
    • 17.3.2. By Product Type
    • 17.3.3. By Application
    • 17.3.4. By Sample
    • 17.3.5. By End User
  • 17.4. Market Trends
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. India Molecular Transport Medium Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Product Type
        • 17.7.1.2.2. By Application
        • 17.7.1.2.3. By Sample
        • 17.7.1.2.4. By End User
    • 17.7.2. Indonesia Molecular Transport Medium Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Product Type
        • 17.7.2.2.2. By Application
        • 17.7.2.2.3. By Sample
        • 17.7.2.2.4. By End User
    • 17.7.3. Vietnam Molecular Transport Medium Market
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Product Type
        • 17.7.3.2.2. By Application
        • 17.7.3.2.3. By Sample
        • 17.7.3.2.4. By End User
    • 17.7.4. Philippines Molecular Transport Medium Market
      • 17.7.4.1. Introduction
      • 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.4.2.1. By Product Type
        • 17.7.4.2.2. By Application
        • 17.7.4.2.3. By Sample
        • 17.7.4.2.4. By End User
    • 17.7.5. Malaysia Molecular Transport Medium Market
      • 17.7.5.1. Introduction
      • 17.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.5.2.1. By Product Type
        • 17.7.5.2.2. By Application
        • 17.7.5.2.3. By Sample
        • 17.7.5.2.4. By End User
    • 17.7.6. Thailand Molecular Transport Medium Market
      • 17.7.6.1. Introduction
      • 17.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.6.2.1. By Product Type
        • 17.7.6.2.2. By Application
        • 17.7.6.2.3. By Sample
        • 17.7.6.2.4. By End User

18. East Asia Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 18.3. Market Size (US$ Bn) Forecast by Market Taxonomy, 2024-2032
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Product Type
    • 18.3.3. By Application
    • 18.3.4. By Sample
    • 18.3.5. By End User
  • 18.4. Market Trends
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. China Molecular Transport Medium Market
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Product Type
        • 18.7.1.2.2. By Application
        • 18.7.1.2.3. By Sample
        • 18.7.1.2.4. By End User
    • 18.7.2. Japan Molecular Transport Medium Market
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Product Type
        • 18.7.2.2.2. By Application
        • 18.7.2.2.3. By Sample
        • 18.7.2.2.4. By End User
    • 18.7.3. South Korea Molecular Transport Medium Market
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Product Type
        • 18.7.3.2.2. By Application
        • 18.7.3.2.3. By Sample
        • 18.7.3.2.4. By End User

19. Oceania Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 19.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product Type
    • 19.3.3. By Application
    • 19.3.4. By Sample
    • 19.3.5. By End User
  • 19.4. Market Trends
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Molecular Transport Medium Market
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Product Type
        • 19.7.1.2.2. By Application
        • 19.7.1.2.3. By Sample
        • 19.7.1.2.4. By End User
    • 19.7.2. New Zealand Molecular Transport Medium Market
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Product Type
        • 19.7.2.2.2. By Application
        • 19.7.2.2.3. By Sample
        • 19.7.2.2.4. By End User

20. Middle East and Africa (MEA) Molecular Transport Medium Market Analysis 2019-2023 and Forecast 2024-2032

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) Analysis by Market Taxonomy, 2019-2023
  • 20.3. Market Size (US$ Bn) and Forecast by Market Taxonomy, 2024-2032
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. Israel
      • 20.3.1.4. North Africa
      • 20.3.1.5. South Africa
      • 20.3.1.6. Rest of Middle East and Africa
    • 20.3.2. By Product Type
    • 20.3.3. By Application
    • 20.3.4. By Sample
    • 20.3.5. By End User
  • 20.4. Market Trends
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Molecular Transport Medium Market
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Product Type
        • 20.7.1.2.2. By Application
        • 20.7.1.2.3. By Sample
        • 20.7.1.2.4. By End User
    • 20.7.2. Israel Molecular Transport Medium Market
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Product Type
        • 20.7.2.2.2. By Application
        • 20.7.2.2.3. By Sample
        • 20.7.2.2.4. By End User
    • 20.7.3. Turkey Molecular Transport Medium Market
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Product Type
        • 20.7.3.2.2. By Application
        • 20.7.3.2.3. By Sample
        • 20.7.3.2.4. By End User
    • 20.7.4. South Africa Molecular Transport Medium Market
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.4.2.1. By Product Type
        • 20.7.4.2.2. By Application
        • 20.7.4.2.3. By Sample
        • 20.7.4.2.4. By End User
    • 20.7.5. North Africa Molecular Transport Medium Market
      • 20.7.5.1. Introduction
      • 20.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.5.2.1. By Product Type
        • 20.7.5.2.2. By Application
        • 20.7.5.2.3. By Sample
        • 20.7.5.2.4. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Concentration
  • 21.4. Market Presence Analysis
    • 21.4.1. Regional footprint of Players
    • 21.4.2. Product footprint by Players
    • 21.4.3. Channel Foot Print by Players

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Thermo Fisher Scientific
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.1.4. Sales Footprint
      • 22.3.1.5. Strategy Overview
      • 22.3.1.6. Key Developments
      • 22.3.1.7. SWOT Analysis
    • 22.3.2. Becton Dickinson and Company
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.2.4. Sales Footprint
      • 22.3.2.5. Strategy Overview
      • 22.3.2.6. Key Developments
      • 22.3.2.7. SWOT Analysis
    • 22.3.3. Cardinal Health
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.3.4. Sales Footprint
      • 22.3.3.5. Strategy Overview
      • 22.3.3.6. Key Developments
      • 22.3.3.7. SWOT Analysis
    • 22.3.4. Quidel Corporation
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.4.4. Sales Footprint
      • 22.3.4.5. Strategy Overview
      • 22.3.4.6. Key Developments
      • 22.3.4.7. SWOT Analysis
    • 22.3.5. Medical Wire & Equipment (MWE)
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.5.4. Sales Footprint
      • 22.3.5.5. Strategy Overview
      • 22.3.5.6. Key Developments
      • 22.3.5.7. SWOT Analysis
    • 22.3.6. COPAN Diagnostics Inc. [COPAN Group]
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.6.4. Sales Footprint
      • 22.3.6.5. Strategy Overview
      • 22.3.6.6. Key Developments
      • 22.3.6.7. SWOT Analysis
    • 22.3.7. Titan Biotech Ltd.
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.7.4. Sales Footprint
      • 22.3.7.5. Strategy Overview
      • 22.3.7.6. Key Developments
      • 22.3.7.7. SWOT Analysis
    • 22.3.8. Alpha Teknova, Inc. [formerly named Teknova]
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.8.4. Sales Footprint
      • 22.3.8.5. Strategy Overview
      • 22.3.8.6. Key Developments
      • 22.3.8.7. SWOT Analysis
    • 22.3.9. Bio-Genex Laboratories Inc.
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.9.4. Sales Footprint
      • 22.3.9.5. Strategy Overview
      • 22.3.9.6. Key Developments
      • 22.3.9.7. SWOT Analysis
    • 22.3.10. EKF Diagnostics
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.10.4. Sales Footprint
      • 22.3.10.5. Strategy Overview
      • 22.3.10.6. Key Developments
      • 22.3.10.7. SWOT Analysis
    • 22.3.11. Trinity Biotech
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.11.4. Sales Footprint
      • 22.3.11.5. Strategy Overview
      • 22.3.11.6. Key Developments
      • 22.3.11.7. SWOT Analysis
    • 22.3.12. Alpha-Tec Systems, Inc.
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.12.4. Sales Footprint
      • 22.3.12.5. Strategy Overview
      • 22.3.12.6. Key Developments
      • 22.3.12.7. SWOT Analysis
    • 22.3.13. Charm Sciences, Inc.
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.13.4. Sales Footprint
      • 22.3.13.5. Strategy Overview
      • 22.3.13.6. Key Developments
      • 22.3.13.7. SWOT Analysis
    • 22.3.14. Azer Scientific
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.14.4. Sales Footprint
      • 22.3.14.5. Strategy Overview
      • 22.3.14.6. Key Developments
      • 22.3.14.7. SWOT Analysis
    • 22.3.15. bioBoaVista
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.15.4. Sales Footprint
      • 22.3.15.5. Strategy Overview
      • 22.3.15.6. Key Developments
      • 22.3.15.7. SWOT Analysis
    • 22.3.16. AccuGene
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.16.4. Sales Footprint
      • 22.3.16.5. Strategy Overview
      • 22.3.16.6. Key Developments
      • 22.3.16.7. SWOT Analysis
    • 22.3.17. KSL Diagnostics
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.17.4. Sales Footprint
      • 22.3.17.5. Strategy Overview
      • 22.3.17.6. Key Developments
      • 22.3.17.7. SWOT Analysis
    • 22.3.18. Puritan Medical Products
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.18.4. Sales Footprint
      • 22.3.18.5. Strategy Overview
      • 22.3.18.6. Key Developments
      • 22.3.18.7. SWOT Analysis
    • 22.3.19. Amazing Biotech (Shanghai) Co., Ltd.
      • 22.3.19.1. Overview
      • 22.3.19.2. Product Portfolio
      • 22.3.19.3. Key Financials by Market Segments (Product/Channel/Region)
      • 22.3.19.4. Sales Footprint
      • 22.3.19.5. Strategy Overview
      • 22.3.19.6. Key Developments
      • 22.3.19.7. SWOT Analysis

23. Assumptions and Acronyms Used

24. Research Methodology